152 related articles for article (PubMed ID: 9781625)
1. Effects of oral combined hormone replacement therapy on plasma lipids and lipoproteins.
Vadlamudi S; MacLean P; Israel RG; Marks RH; Hickey M; Otvos J; Barakat H
Metabolism; 1998 Oct; 47(10):1222-6. PubMed ID: 9781625
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
3. Effects of continuous low-dosage hormonal replacement therapy on lipoprotein metabolism in postmenopausal women.
Wolfe BM; Huff MW
Metabolism; 1995 Mar; 44(3):410-7. PubMed ID: 7885290
[TBL] [Abstract][Full Text] [Related]
4. Positive correlation between circulating leptin levels and lipid lipoproteins in postmenopausal women administered hormone replacement therapy.
Kanda T; Ichikawa S; Sumino H; Sakamaki T; Nakamura T; Tsukui S; Nara M; Kobayashi I; Tamura J
Res Commun Mol Pathol Pharmacol; 2000; 107(3-4):179-85. PubMed ID: 11484873
[TBL] [Abstract][Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
6. Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity.
Abbey M; Owen A; Suzakawa M; Roach P; Nestel PJ
Maturitas; 1999 Dec; 33(3):259-69. PubMed ID: 10656504
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
Park JS; Jung HH; Yang WS; Kim SB; Min WK; Chi HS
Nephrol Dial Transplant; 2000 Nov; 15(11):1835-40. PubMed ID: 11071974
[TBL] [Abstract][Full Text] [Related]
8. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
Seed M; Sands RH; McLaren M; Kirk G; Darko D
Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
[TBL] [Abstract][Full Text] [Related]
9. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
[TBL] [Abstract][Full Text] [Related]
10. The effect of sodium monofluorophosphate therapy on lipid and lipoprotein metabolism in postmenopausal women.
Oral B; Ozbaşar D
Eur J Obstet Gynecol Reprod Biol; 2003 Apr; 107(2):180-4. PubMed ID: 12648865
[TBL] [Abstract][Full Text] [Related]
11. Sequential estrogen-progestin replacement therapy in healthy postmenopausal women: effects on cholesterol efflux capacity and key proteins regulating high-density lipoprotein levels.
Ulloa N; Arteaga E; Bustos P; Durán-Sandoval D; Schulze K; Castro G; Jauhiainen M; Fruchart JC; Calvo C
Metabolism; 2002 Nov; 51(11):1410-7. PubMed ID: 12404190
[TBL] [Abstract][Full Text] [Related]
12. Physical activity, hormone replacement therapy and plasma lipoprotein-lipid levels in postmenopausal women.
Hagberg JM; McCole SD; Ferrell RE; Zmuda JM; Rodgers KS; Wilund KR; Moore GE
Int J Sports Med; 2003 Jan; 24(1):22-9. PubMed ID: 12582948
[TBL] [Abstract][Full Text] [Related]
13. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
Gevers Leuven JA; van der Mooren MJ; Buytenhek R
Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
[TBL] [Abstract][Full Text] [Related]
14. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women.
Granfone A; Campos H; McNamara JR; Schaefer MM; Lamon-Fava S; Ordovas JM; Schaefer EJ
Metabolism; 1992 Nov; 41(11):1193-8. PubMed ID: 1435290
[TBL] [Abstract][Full Text] [Related]
15. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy.
Heikkinen AM; Tuppurainen MT; Niskanen L; Komulainen M; Penttilä I; Saarikoski S
Eur J Endocrinol; 1997 Nov; 137(5):495-502. PubMed ID: 9405029
[TBL] [Abstract][Full Text] [Related]
16. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
Walsh BW; Kuller LH; Wild RA; Paul S; Farmer M; Lawrence JB; Shah AS; Anderson PW
JAMA; 1998 May; 279(18):1445-51. PubMed ID: 9600478
[TBL] [Abstract][Full Text] [Related]
17. Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy.
Somekawa Y; Wakabayashi A
Eur J Obstet Gynecol Reprod Biol; 1998 Aug; 79(2):185-91. PubMed ID: 9720839
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
[TBL] [Abstract][Full Text] [Related]
19. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women.
Lindheim SR; Notelovitz M; Feldman EB; Larsen S; Khan FY; Lobo RA
Obstet Gynecol; 1994 Feb; 83(2):167-72. PubMed ID: 8290176
[TBL] [Abstract][Full Text] [Related]
20. The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors.
Tikkanen MJ
Maturitas; 1996 Mar; 23(2):209-16. PubMed ID: 8735358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
